Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GLYC - GlycoMimetics A Buy On Potential 2022 AML Data
May, 19 2021 09:06 AM
GlycoMimetics Inc.
GlycoMimetics is priced based on a prior Phase 3 clinical trial failure. But it had strong Phase 2 acute myeloid leukemia data. The Phase 3 AML trial is expected to complete enrollment in late 2021. For further details see:
GlycoMimetics A Buy On Potential 2022 AML Data
Stock Information
Company Name:
GlycoMimetics Inc.
Stock Symbol:
GLYC
Market:
NASDAQ
Website:
glycomimetics.com
Get GLYC Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .